Personalis, Inc. Skyrocketed

Fri, Jul 05, 2024 at 07:05 PM

Personalis, Inc. (PSNL:NASDAQ) jumped higher at $1.53, representing a gain of 28.6%. On Fri, Jul 05, 2024, PSNL:NASDAQ hit a New 2-Week High of $1.53. The stock appeared on our News Catalysts scanner on Tue, Jun 18, 2024 at 05:44 PM in the 'MISCELLANEOUS' category. From Fri, Jun 21, 2024, the stock recorded 55.56% Up Days and 30.00% Green Days

About Personalis, Inc. (PSNL:NASDAQ)

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

Top 10 Gainers:

Beneficient (BENF:NASDAQ), 125.12%
Qualigen Therapeutics Inc. (QLGN:NASDAQ), 59.64%
Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 49.63%
Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
Bite Acquisition Corp. (BITE:NYSE), 43.68%
Maxeon Solar Technologies Ltd. (MAXN:NASDAQ), 38.25%
XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 36.14%
MediWound Ltd. (MDWD:NASDAQ), 35.08%
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 29.18%
Personalis, Inc. (PSNL:NASDAQ), 28.57%